INTELLIA THERAPEUTICS INC. - COMMON STOCK

9.6400

13-February-25 16:45:00

15 minutes delayed

Stocks

+0.1300

+1.37%

Today's range

9.3301 - 9.7150

ISIN

N/A

Source

NASDAQ

NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

12 Feb 2025 09:45:14 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

11 Feb 2025 09:48:06 By NetDania Notify
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

04 Feb 2025 16:01:00 By Nasdaq GlobeNewswire
Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema

22 Jan 2025 07:30:00 By Nasdaq GlobeNewswire
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

16 Jan 2025 10:00:04 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

14 Jan 2025 15:48:02 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

13 Jan 2025 09:46:31 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

10 Jan 2025 09:45:07 By NetDania Notify
Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement of its Late-Stage Programs, NTLA-2002 and Nexiguran Ziclumeran (nex-z)

09 Jan 2025 16:00:00 By Nasdaq GlobeNewswire
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 Jan 2025 07:30:00 By Nasdaq GlobeNewswire
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

31 Dec 2024 10:00:10 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

30 Dec 2024 09:52:39 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

26 Dec 2024 09:45:05 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

19 Dec 2024 09:59:11 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

18 Dec 2024 14:25:27 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

13 Dec 2024 10:50:31 By NetDania Notify
Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

03 Dec 2024 16:01:00 By Nasdaq GlobeNewswire
Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy

25 Nov 2024 07:30:00 By Nasdaq GlobeNewswire
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

20 Nov 2024 09:51:21 By NetDania Notify
NetDania - New 12 months Low: INTELLIA THERAPEUTICS INC. - COMMON STOCK

18 Nov 2024 10:10:43 By NetDania Notify

<<
<
1
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.